Funding for this research was provided by:
Institute of Cancer Research (MOP-142233)
Received: 4 April 2018
Accepted: 1 August 2018
First Online: 15 October 2018
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Specifically, for the 23 patients who received only empiric PRRT until March 2016, the requirement for consent was waived due to the retrospective nature of the analysis. All other patients were enrolled in our P-PRRT trial (NCT02754297) and gave informed consent to participate.
: All authors read the manuscript and consented for its publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.